Login to Your Account



Inspire Drug for Cystic Fibrosis Fares Well in Phase III Test

By Catherine Hollingsworth


Monday, June 9, 2008
Inspire Pharmaceuticals said its drug for cystic fibrosis, denufosol, was shown to improve the ability of patients to exhale compared to placebo in a six-month study, an announcement that drew cheers from Wall Street in the form of a 34.8 percent stock price boost. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription